Rapid Micro Biosystems (NASDAQ:RPID) Stock Rating Raised to Strong-Buy at Roth Capital

Roth Capital upgraded shares of Rapid Micro Biosystems (NASDAQ:RPID) to a strong-buy rating in a research note released on Tuesday morning,Zacks reports.

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rapid Micro Biosystems in a report on Friday, July 17th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $5.00.

Rapid Micro Biosystems Trading Down 1.4%

NASDAQ:RPID opened at $1.08 on Tuesday. The company’s 50 day moving average is $1.56 and its 200-day moving average is $1.93. The company has a quick ratio of 1.51, a current ratio of 2.55 and a debt-to-equity ratio of 1.08. Rapid Micro Biosystems has a 12 month low of $1.06 and a 12 month high of $4.94. The firm has a market cap of $54.17 million, a price-to-earnings ratio of -0.96 and a beta of 1.43.

Rapid Micro Biosystems (NASDAQ:RPID) last announced its earnings results on Friday, August 7th. The company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.24) by ($0.03). Rapid Micro Biosystems had a negative net margin of 145.56% and a negative return on equity of 177.04%. The business had revenue of $8.05 million for the quarter, compared to the consensus estimate of $7.88 million. Equities analysts anticipate that Rapid Micro Biosystems will post -0.91 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Evernest Financial Advisors LLC grew its position in shares of Rapid Micro Biosystems by 246.0% in the 1st quarter. Evernest Financial Advisors LLC now owns 432,510 shares of the company’s stock valued at $1,021,000 after purchasing an additional 307,510 shares during the period. Fifth Lane Capital LP bought a new position in Rapid Micro Biosystems in the fourth quarter valued at $51,000. Bank of America Corp DE increased its position in shares of Rapid Micro Biosystems by 139.9% in the first quarter. Bank of America Corp DE now owns 31,014 shares of the company’s stock valued at $70,000 after acquiring an additional 18,085 shares during the last quarter. Renaissance Technologies LLC increased its position in shares of Rapid Micro Biosystems by 9.5% during the 1st quarter. Renaissance Technologies LLC now owns 126,617 shares of the company’s stock worth $287,000 after purchasing an additional 10,990 shares during the last quarter. Finally, Sei Investments Co. increased its holdings in Rapid Micro Biosystems by 204.2% during the first quarter. Sei Investments Co. now owns 284,816 shares of the company’s stock worth $647,000 after buying an additional 191,200 shares during the last quarter. 52.60% of the stock is currently owned by institutional investors.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc develops automated solutions for detecting and monitoring microbial contamination in pharmaceutical, biotechnology, and other regulated manufacturing environments. Its technologies are designed to help companies replace or reduce manual, labor-intensive microbiological testing processes while supporting quality control and regulatory compliance.

The company’s primary offering is the Growth Direct platform, an automated microbial detection system that combines instrumentation, consumables, and software.